Navigation Links
Repligen Reports Second Quarter Fiscal Year 2011 Financial Results
Date:11/2/2010

ORPORATIONSTATEMENTS OF OPERATIONS(Unaudited) Three months ended September 30, Six months ended September 30, 2010200920102009Revenue:Product revenue

$
4,415,786 $
2,741,578 $
8,684,598 $
5,214,168 Royalty and other revenue2,891,192 2,679,016 5,632,252 5,267,279 Total revenue7,306,978 5,420,594 4,316,850 ,481,447 Operating expenses:Cost of product revenue,471,561 918,464 2,737,311 2,188,938 Cost of royalty and other revenue376,991 341,057 748,733 58,803 Research and development3,119,279 3,478,845 5,814,327 ,861,845 Selling, general and administrative,812,617 ,888,619 3,600,854 3,405,975 Total operating expenses,780,448 ,626,985 2,901,225 3,115,561 Income (loss) from operations526,530 (1,206,391),415,625 (2,634,114)Investment income96,679 227,364 95,637 549,783 Interest expense-   (676)- (1,352)Income (loss) before income taxes23,209 (979,703),611,262 (2,085,683)Income tax (benefit) provision-   -   -   -   Net income (loss)

$
23,209 $
(979,703) $
,611,262 $
(2,085,683)Earnings (loss) per share:Basic

$
.02 $
(0.03) $
.05 $
(0.07)Diluted

$
.02 $
(0.03) $
.05 $
(0.07)Weighted average shares outstanding:Basic30,780,279 30,745,691 30,773,967 30,743,961 Diluted30,920,400 30,745,691 30,922,474 30,743,961 Balance Sheet Data:

September 30, 2010March 31, 2010Cash, cash equivalents and marketable securities*

$
59,691,183 $
59,146,447 Working capital,551,729 55,023,895 Total assets72,627,865 71,419,963 Long-term obligations20,149 42,447 Accumulated deficit(116,309,843)(117,921,105)Stockholders' equity8,262,408 ,120,376 *does not include restricted cashThis press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not const
'/>"/>

SOURCE Repligen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Repligen Receives Research Grants to Support Friedreichs Ataxia Development Program
2. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
3. Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT
4. Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Monday, November 10th, 4:55 p.m. EST
5. Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results
6. Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST
7. Repligen Reports Third Quarter Fiscal Year 2009 Financial Results
8. Repligen to Present at the Cowen and Company 29th Annual Healthcare Conference Monday, March 16th, 2:25 p.m. EDT
9. Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results
10. Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results
11. Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 ... biological drugs to treat cancer, viral infections and ... Sir John Bell , the Regius Professor ... the Office for the Strategic Coordination of Health ... effect.      (Photo: http://photos.prnewswire.com/prnh/20150330/736483 ...
(Date:3/30/2015)... and MADISON, Wis. , March ... Nakajima ,) (TSE: 4901) ("Fujifilm") and Cellular Dynamics International, ... ICEL ) ("CDI"), a leading developer and manufacturer of ... specifications, today announced that the two companies have entered ... via an all-cash tender offer to be followed by ...
(Date:3/29/2015)... Texas , March 29, 2015 /PRNewswire/ ... presentation of important study data showing the ... in 1,599 gynecologic cancer samples. Using Caris ... profiling service, researchers identified expression of programmed ... cancers independent of histology while its ligand ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 The consumption ... back of the recession and high prices in 2008. ... has recovered and keeps on gaining momentum now. , ... stands at more than 100,000 thousand tonnes. No considerable ... Meantime, the global capacity rocketed during 2012-2013, registering 11% ...
Breaking Biology Technology:Immunocore Appoints Professor Sir John Bell to its Board of Directors 2Immunocore Appoints Professor Sir John Bell to its Board of Directors 3Immunocore Appoints Professor Sir John Bell to its Board of Directors 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 2Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 4Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 6Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 7Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 8Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3
... 27, 2008 - Vol. 299. No. 8: ,Venous Thromboembolism ... Administration for the Treatment of ... Biotech believes that,the conclusions of a study published in ... American Medical Association (JAMA) by Bennett, et al, do,not ...
... Colo., Feb. 26 Replidyne, Inc.,(Nasdaq: RDYN ) today ... ended December 31, 2007., Replidyne reported a net loss ... or a net loss per basic and diluted common share,of ... million, or $0.36 per,basic and diluted common share, for the ...
... Firms Recommend Pharmion ... merger with Celgene Special Meeting ... Corp. Urges All Shareholders to Vote FOR the Proposed Merger, ... ) today announced that Institutional Shareholder Services,(ISS) has recommended that ...
Cached Biology Technology:Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents 2Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents 3Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents 4Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents 5Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents 6Replidyne Announces 2007 Fourth Quarter and Full Year Results 2Replidyne Announces 2007 Fourth Quarter and Full Year Results 3Replidyne Announces 2007 Fourth Quarter and Full Year Results 4Replidyne Announces 2007 Fourth Quarter and Full Year Results 5Replidyne Announces 2007 Fourth Quarter and Full Year Results 6Replidyne Announces 2007 Fourth Quarter and Full Year Results 7ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 2ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 3
(Date:3/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/48tj8z/global_biometrics ... "Global Biometrics Market Forecast and Opportunities, 2020" ... for biometric authentication systems is projected to grow ... The driving forces for this highly ... projects and constant development in technology. In 2014, ...
(Date:3/2/2015)... JOSE, Calif. , March 2, 2015 /PRNewswire/ ... the leading developer of human interface solutions, today ... technology that is designed to enable rapid and ... Natural ID™ module for gaming is a turnkey ... ODMs the ability to quickly integrate fingerprint ID ...
(Date:3/2/2015)... VILNIUS, Lithuania , March 2, 2015   ... AI technologies, today introduced the SentiGaze Software Development ... developers to create applications that use off-the-shelf webcams to ... a user gazes at a monitor. Heatmaps can be ... determining the effectiveness of online advertising. The SDK can ...
Breaking Biology News(10 mins):Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3
... a new location or go extinct as a result of ... Northern England seem to defy the odds and adapt to ... study by scientists from Syracuse University and the University of ... of the Early Edition of the Proceedings of the ...
... -- The Soil Science Society of America (SSSA) applauds ... his colleagues in the Senate who helped usher in ... placing soil on par with water and air. ... Senators Kent Conrad (D-ND), Charles Grassley (R-IA), Russ Feingold ...
... lenses are joining the trend to go green. Chemical ... fluid found in our bodies can be used as a ... step up from the current wave of self-moisturizing contact lenses ... eye dryness and increase wearer comfort. It is estimated ...
Cached Biology News:New study finds that some plants can adapt to widespread climate change 2Senate resolution shines spotlight on the importance of soils 2Self-moisturizing contact lenses, naturally 2
ABI 432 Resins • Gln(Trt) Peptide Synthesis Column...
The E. coli Expression System with Gateway Technology is designed to create E. coli expression clones containing the T7 promoter. The expression clones are ready for transformation and expression in ...
...
Human RUNX2/CBFA1 MAb (Clone 232902)...
Biology Products: